NovaBridge Biosciences (NBP) EPS (Weighted Average and Diluted) (2019 - 2025)
NovaBridge Biosciences (NBP) reported EPS (Weighted Average and Diluted) of -$0.33 for Q4 2025, up 100.0% quarter-over-quarter from -$40164.7 in Q3 2025.
NovaBridge Biosciences (NBP) EPS (Weighted Average and Diluted) (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has 5 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.33 in Q4 2025.
- EPS (Weighted Average and Diluted) for Q4 2025 came in at -$0.33, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$0.33 (changed N/A YoY), and the FY2025 annual result was -$0.21, up 22.22% from the prior year.
- EPS (Weighted Average and Diluted) rose to -$0.33 in Q4 2025 per NBP's latest filing, from -$40164.7 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $228418.2 in Q2 2024 and troughed at -$146364.3 in Q3 2024.
- A 3-year average of -$1018.7 and a median of -$1.29 in 2025 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2024 and 2025: EPS (Weighted Average and Diluted) jumped 10151625.9% in 2024, then sank 121.91% in 2025.
- A 3-year view of EPS (Weighted Average and Diluted) shows it stood at -$2.25 in 2023, then plunged by 6504727.36% to -$146364.3 in 2024, then jumped by 100.0% to -$0.33 in 2025.
- Business Quant data shows NBP's EPS (Weighted Average and Diluted) at -$0.33 in Q4 2025, -$40164.7 in Q3 2025, and -$50036.4 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 0.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -0.61 |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | -0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.33 |
| Sep 30, 2025 | -40,164.71 |
| Jun 30, 2025 | -50,036.36 |
| Mar 31, 2025 | -0.02 |
| Sep 30, 2024 | -146,364.29 |
| Jun 30, 2024 | 228,418.18 |
| Mar 31, 2024 | -0.04 |
| Jun 30, 2023 | -2.25 |
| Dec 31, 2020 | 347,183.33 |
| Dec 31, 2019 | -51.70 |